| Company Name: |
Shanghai Topbiochem Technology Co., Ltd
|
| Tel: |
021-58170097 |
| Email: |
info@topbiochem.com |
| Products Intro: |
Product Name:5,8-dioxo-6-(pyridin-3-ylamino)naphthalene-1-sulfonamide CAS:1436382-03-4 Purity:95% Package:10g;100g;1kg
|
5,8-dioxo-6-(pyridin-3-ylamino)naphthalene-1-sulfonamide manufacturers
- LY5
-
- $954.00
-
2026-04-20
- CAS:1436382-03-4
- Purity:
- Supply Ability: 10g
|
| | 5,8-dioxo-6-(pyridin-3-ylamino)naphthalene-1-sulfonamide Basic information |
| Product Name: | 5,8-dioxo-6-(pyridin-3-ylamino)naphthalene-1-sulfonamide | | Synonyms: | 5,8-dioxo-6-(pyridin-3-ylamino)naphthalene-1-sulfonamide;1-Naphthalenesulfonamide, 5,8-dihydro-5,8-dioxo-6-(3-pyridinylamino)-;5,8-Dioxo-6-(pyridin-3-ylamino)-5,8-dihydro-naphthalene-1-sulfonicacidamide;5,8-dioxo-6-(pyridin-3-ylamino)-5,8-dihydronaphthalene-1-sulfonamide | | CAS: | 1436382-03-4 | | MF: | C15H11N3O4S | | MW: | 329.33 | | EINECS: | | | Product Categories: | | | Mol File: | 1436382-03-4.mol |  |
| | 5,8-dioxo-6-(pyridin-3-ylamino)naphthalene-1-sulfonamide Chemical Properties |
| Boiling point | 635.6±65.0 °C(Predicted) | | density | 1.585±0.06 g/cm3(Predicted) | | storage temp. | Store at -20°C | | pka | 9.15±0.20(Predicted) |
| | 5,8-dioxo-6-(pyridin-3-ylamino)naphthalene-1-sulfonamide Usage And Synthesis |
| Description | LY5 is a STAT3 inhibitor. It acts by inhibiting cell viability, cell migration, and angiogenesis in medulloblastoma cells. | | Uses | LY5 is a STAT3 inhibitor with an IC50 value of 0.5 μM. LY5 induces apoptosis and inhibits STAT3 phosphorylation. LY5 shows antitumor activity in vivo, it can be used for the research of cancer[1]. | | in vivo | LY5 (5 mg/kg; i.p. once daily for 21 days) inhibits breast tumor growth in vivo[1]. | Animal Model: | Nude mice with MDA-MB-231 cancer cells injection[1] | | Dosage: | 5 mg/kg | | Administration: | Intraperitoneal injection; 5 mg/kg; once daily; for 21 days | | Result: | Suppressed tumor growth and significantly reduced the tumor sizes.
|
| | References | [1] Yu W, et al. Discovery of novel STAT3 small molecule inhibitors via in silico site-directed fragment-based drug design. J Med Chem. 2013 Jun 13;56(11):4402-12. DOI:10.1021/jm400080c |
| | 5,8-dioxo-6-(pyridin-3-ylamino)naphthalene-1-sulfonamide Preparation Products And Raw materials |
|